U.S. Top Stock Picks from Analysts

UnitedHealth Group

Market Cap: US$282.5b

Operates as a health care company in the United States and internationally.

BeiGene

Market Cap: US$24.3b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

Summit Therapeutics

Market Cap: US$18.3b

A biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies.

Aurora Innovation

Market Cap: US$12.9b

Operates as a self-driving technology company in the United States.

BioMarin Pharmaceutical

Market Cap: US$11.5b

A biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally.

Moderna

Market Cap: US$9.9b

A biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally.

AST SpaceMobile

Market Cap: US$8.7b

Designs and develops the constellation of BlueBird satellites in the United States.

VinFast Auto

Market Cap: US$8.7b

Engages in the design and manufacture of electric vehicles (EV), e-scooters, and e-buses in Vietnam, Canada, and the United States.

Roivant Sciences

Market Cap: US$7.7b

A commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for inflammation and immunology areas.

Corcept Therapeutics

Market Cap: US$7.5b

Engages in discovery and development of medication for the treatment of severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.

Revolution Medicines

Market Cap: US$7.4b

A clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.

UWM Holdings

Market Cap: US$6.8b

Engages in the origination, sale, and servicing residential mortgage lending in the United States.

Jazz Pharmaceuticals

Market Cap: US$6.3b

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally.

BridgeBio Pharma

Market Cap: US$6.3b

A commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers.

Legend Biotech

Market Cap: US$5.7b

Through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.

Bruker

Market Cap: US$5.6b

Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.

GDS Holdings

Market Cap: US$5.5b

Develops and operates data centers in the People's Republic of China.

Lantheus Holdings

Market Cap: US$5.5b

Develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide.

Axsome Therapeutics

Market Cap: US$5.2b

A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.

Ionis Pharmaceuticals

Market Cap: US$5.2b

A commercial-stage biotechnology company, provides RNA-targeted medicines in the United States.

Nuvalent

Market Cap: US$5.1b

A clinical-stage biopharmaceutical company, engages in the development of therapies for patients with cancer.

ChampionX

Market Cap: US$5.0b

Provides chemistry solutions, artificial lift systems, and engineered equipment and technologies to oil and gas companies worldwide.

Icahn Enterprises

Market Cap: US$5.0b

Through its subsidiaries engages in the investment, energy, automotive, food packaging, real estate, home fashion and pharma in the United States and internationally.

ADMA Biologics

Market Cap: US$4.7b

A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.

BGC Group

Market Cap: US$4.5b

Operates as a financial brokerage and technology company in the United States, Europe, the Middle East, Africa, and the Asia Pacific.

Core Natural Resources

Market Cap: US$3.9b

Produces, sells, and exports metallurgical and thermal coals in the United States and internationally.

Krystal Biotech

Market Cap: US$3.9b

A commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States.

Abercrombie & Fitch

Market Cap: US$3.9b

Through its subsidiaries, operates as an omnichannel retailer in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific.

Vaxcyte

Market Cap: US$3.9b

A clinical-stage vaccine innovation company, develops conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases.

Telephone and Data Systems

Market Cap: US$3.8b

A telecommunications company, provides communications services to consumer, business, and government in the United States.

Soleno Therapeutics

Market Cap: US$3.8b

A clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases.

GEO Group

Market Cap: US$3.7b

Owns, leases, operates, and manages secure facilities, processing centers, and community-based reentry facilities in the United States, Australia, the United Kingdom, and South Africa.

Cytokinetics

Market Cap: US$3.7b

A late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases in the United States.

Avidity Biosciences

Market Cap: US$3.6b

A biopharmaceutical company, engages in the delivery of RNA therapeutics called antibody oligonucleotide conjugates (AOCs).

Sarepta Therapeutics

Market Cap: US$3.6b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Zeta Global Holdings

Market Cap: US$3.5b

Operates an omnichannel data-driven cloud platform that provides enterprises with consumer intelligence and marketing automation software in the United States and internationally.